Znanstveni rad - Izvorni znanstveni rad
Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study
Frontiers in Immunology, 13 (2022); 88493. https://doi.org/10.3389/fimmu.2022.884931


Citirajte ovaj rad

Miše, J., Lakoš Jukić, I. i Marinović, B. (2022). Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study. Frontiers in Immunology, 13.. doi: 10.3389/fimmu.2022.884931

Miše, Joško, et al. "Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study." Frontiers in Immunology, vol. 13, 2022. https://doi.org/10.3389/fimmu.2022.884931

Miše, Joško, Ines Lakoš Jukić i Branka Marinović. "Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study." Frontiers in Immunology 13 (2022). https://doi.org/10.3389/fimmu.2022.884931

Miše, J., Lakoš Jukić, I. i Marinović, B. (2022) 'Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study', Frontiers in Immunology, 13. doi: 10.3389/fimmu.2022.884931

Miše J, Lakoš Jukić I, Marinović B. Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study. Frontiers in Immunology [Internet]. 2022. [pristupljeno 14.06.2024.];13. doi: 10.3389/fimmu.2022.884931

J. Miše, I. Lakoš Jukić i B. Marinović, "Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study", Frontiers in Immunology, vol. 13, 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:356133. [Citirano: 14.06.2024.]